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By age two a child who is up to date for immunizations will have received up to19 shots delivered over
eight visits at a market cost of $525 dollars for the vaccines alone, a far more expensive and demanding
regimen that the 8 shots received in 1987. In recognition of the potential importance of health insurance
to immunization coverage rates, the State Children's Health Insurance Program (SCHIP) mandated that
all plans cover the cost and administration of childhood vaccines. We use data from the recently released
National Immunization Survey for the years 1995 to 2001 to test whether SCHIP was associated with
differential changes among poor and near-poor children relative to their non-poor counterparts in either
age-appropriate immunization rates or in the proportion of vaccines delivered by private providers. We
show that the probability that a child was up to date for the varicella vaccine increased between 7 and
16 percentage points more among poor and near-poor relative to non-poor children after implementation
of SCHIP. The increase was greater among children from urban areas, among Hispanics and among
those from states with the highest rates of uninsured children prior to SCHIP than among children
nationally. We found small to inconsequential changes for other vaccines. We also found that the
probability that a poor or near-poor child obtained all vaccines at a private provider fell relative to the
same probability among non-poor children over the study period. SCHIP appears to have affected the
uptake of a recently introduced vaccine, which suggests that insurance coverage may be important for
the rapid adoption of the latest and increasingly more expensive agents such as the pneumococcal
conjugate vaccine.
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I. Introduction 
The Balanced Budget Act of 1997 established the State Children’s Health Insurance 
Program or SCHIP.  The Program makes available health insurance to children in near-poor 
families that are ineligible for Medicaid.  The 40 billion dollars appropriated over ten years for 
SCHIP represents the largest extension of publicly provided health insurance since Medicaid. 
The motivation came from the high rates of uninsured children among the working poor.   
Approximately, 23 percent of children from families with incomes between 100 and 200 percent 
of the federal poverty level (FPL) and 27 percent of children in poverty lacked health insurance 
in 1996 (Dubay, Kenny and Haley 2000).  A recent analysis indicates that the proportion of 
children without insurance for some part of the year may be as high as 40 percent (Congressional 
Budget Office 2003). 
Efforts to evaluate SCHIP have largely focused on take up rates (Dubay, Kenny and 
Haley 2000; LoSasso and Buchmueller 2002).   The few studies of outcomes pertain to the 
precursors of SCHIP in selected states and have focused primarily on changes in utilization 
(Lave et al. 1998 ; Szilagyi et al. 2000a).  There is a more extensive literature on the effect of the 
Medicaid eligibility expansions on health care utilization (Currie and Gruber 1996; Newacheck 
et al. 1998; Kaestner, Racine and Joyce 2001; Racine et al. 2001; Lykens and Jargowsky 2002).  
Most researchers have found a positive association between enrollment in Medicaid or 
expansions in Medicaid eligibility and doctor’s visits, hospital admissions and access to a regular 
source of pediatric care. While it is tempting to infer from these results that increased utilization 
leads to better health, the measures of utilization are often too general to draw causal links
 1. 
                                                 
1 The lack of health outcomes sufficiently sensitive to changes in insurance has been a long standing problem in 
attempts to associate insurance and health (Levy and Meltzer 2001) [I don’t see this referenced at the end of the 
paper].     
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Despite the utilization findings, few studies have been able to demonstrate a convincing 
association between changes in insurance and changes in children’s health (Currie and Gruber 
1996; Kenny, Dubay and Haley 2000; Szilagyi et al. 2000b;Lykens and Jargowsky 2002).  The 
infrequency of adverse health events and the invariance of self-reported health have limited the 
power to detect associations.  
In this study we look at the association between SCHIP and childhood immunization 
rates.   We also examine whether children receive vaccines from a single provider, a single 
private provider or one that provides comprehensive pediatric services. Vaccines are a 
particularly useful outcome by which to assess SCHIP.  First, immunization rates are a unique 
measure of utilization because the link between the receipt of vaccines and prevention of vaccine 
preventable illnesses is so direct.   Second, SCHIP legislation specifically mandates that all state 
programs cover the cost and administration of all childhood vaccines as recommended by the 
Advisory Committee on Immunization Practices.
2  Third, immunization rates may be particularly 
sensitive to the ability to pay.  The cost of vaccines has increased dramatically over the past ten 
years.  It now costs $525 at market prices for vaccines alone to fully immunize a child by age 
two.   In addition, there are now up to 19 shots given in the first two years and administered over 
eight visits.  The number of vaccines and the complexity of vaccine schedules make up-to-date 
coverage rates a particularly apt indicator of the quality of primary pediatric care.   Lastly, the 
site at which vaccines are received is also important since each visit offers opportunities for 
general health screening, developmental assessment, injury prevention counseling, nutritional 
guidance, parenting advice and other elements of systematic well-child care.  Children 
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vaccinated in public health clinics that do not offer comprehensive pediatric services may not 
obtain these important assessments.  
This study is the first to associate changes in the availability of insurance to 
immunization rates at the national level.  The expense and complexity associated with the 
documentation of immunizations has limited the scope of previous studies. The recent release of 
the National Immunization Survey (NIS) has made a national study possible. The NIS is a yearly 
population-based survey of more than 30,000 households per year with children between 19 and 
35 months of age.  The NIS has information on vaccine receipt, characteristics of the providers 
as well as social and economic measures of the household.  The availability of this data set 
enables us to address three questions.  1) Are changes in the timing of implementation and 
generosity of state SCHIP income thresholds associated with changes in immunization coverage 
rates among poor and near-poor children?  2) Is the establishment of SCHIP associated with 
changes in the probability that a poor or near-poor child obtains vaccines from a private provider 
or one that offers comprehensive services?  3) How does the availability of publicly provided 
health insurance affect uptake rates of newly introduced vaccines among poor and near-poor 
children.   
II. Background 
US vaccination policy in the 1990s was in large part a response to the resurgence of 
measles in the beginning of the decade. In 1990, the peak year of the resurgence, the incidence of 
measles for children less than 5 years of age was 15 times greater than the median incidence 
between 1981 and 1988.  All totaled, there were over 55,000 cases of measles, 11,000 
hospitalizations and 166 deaths between 1989 and 1991 (Centers for Disease Control and 
Prevention 1992).  The greatest concentration of cases occurred among minority, pre-school   - 4 - 
children in urban centers.  In its assessment of the epidemic, the National Vaccine Advisory 
Committee blamed the low rate of vaccination at the recommended age (National Vaccine 
Advisory Committee 1991).    
The costs of vaccines and inadequate access to pediatric care were viewed as significant 
barriers to early immunization.  In 1993, the Clinton Administration launched the Childhood 
Immunization Initiative, which set goals for coverage rates, outreach, education and financial 
support.  The Vaccine for Children Program (VFC) was implemented in October of 1994 and 
makes free vaccines available through providers to children 18 years of age or younger who are 
eligible for Medicaid, uninsured, Native American or Alaskan Native, or who are underinsured 
and who receive services at a federally qualified health care center (Institute of Medicine 2000).  
SCHIP, with its specific mandate regarding coverage of immunizations, was part of the general 
thrust to insure adequate vaccination rates.  
The availability of free vaccines and the expansion in health insurance for poor and near-
poor children comes at a propitious juncture given the number and costs of vaccinations. There 
are now 19 doses of vaccines that an infant should receive, within the first 18 months (MMWR 
2002), up from 8 in 1987.  Costs of vaccines to fully immunize a child have risen from $116 in 
1987 at private sector prices to $525 in 2002
3.  It is estimated that the administration of vaccines 
costs add an additional $15 per shot in 1995 (Institute of Medicine 2000). The new varicella and 
pneumococcal vaccines cost approximately $45.00  per dose  making them  four to five times 
more expensive than either the combined vaccine for diphtheria, acellular pertussis and tetanus  
(DaPt) or the inactivated vaccine for polio (IPV).   The Institute of Medicine speculates that the 
                                                 
3 Figures for 1987 are from the Institute of Medicine (2000).  Figures for 2002 are based on authors’ calculations 
using prices posted by the Centers for Disease Control and Prevention, 
(http://www.cdc.gov/nip/vfc/cdc_vac_price_list.htm). 
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number of vaccines could triple within the next 20 years (Institute of Medicine 2000), although 
new combination vaccines may serve to simplify the regimen over time
4. 
Growth in the complexity and the cost of the childhood vaccine schedule underscores the 
importance of realized access to comprehensive pediatric care since sporadic visits to a health 
care provider are increasingly less likely to result in complete immunization coverage than 
before.  In this context, the availability of health insurance plays an important role since the cost 
of pediatric health care is a significant determinant of its use. The effect of health insurance on 
the utilization of health care services by children is well-established (Newhouse et al. 1993; 
Currie and Gruber 1996; Newacheck et al. 1998a; Dubay and Kenney 2001).  Health insurance is 
also associated with children having a regular source of care (Newacheck et al. 1998b).   
Unsurprisingly, therefore, health insurance is related to appropriate vaccination rates 
(Lurie et al. 1987).  In a more recent analysis of how financial incentives matter, researchers 
used a randomized design to study the effect of making receipt of welfare benefits contingent 
upon pre-school children being up to date for immunizations.  Children in the experimental 
group were approximately 4 to 6 percentage points more likely to be up to date than children 
from families unexposed to the sanction (Kerpelman, Connell and Gunn 2000).   
There is also evidence that the extension of health insurance to near-poor families is 
associated with increased immunization coverage rates, although it is unclear whether the 
relationship is a causal one.  Researchers examined the effect of New York State’s Child Health 
Plus (CHPlus) program in 1991, a model for the current SCHIP (Rodewald et al. 1997).  Using a  
                                                                                                                                                             
 
4 See, for example, the recent introduction of a combination vaccine for diphtheria and tetanus toxoids, acellular 
pertussis adsorbed, Hepatitis B (recombinant) and poliovirus by GlaxoSmithKline called Pediarix
TM (Centers for 
Disease Control, 2003). 
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pre-post design, they found that up-to-date immunizations among those that had no insurance 
prior to CHPlus increased 5.8 percentage points after implementation.  However, there was a 
similar increase among those who were always insured (4.0 percentage points).  Thus, it was 
unclear whether the increase was attributable to CHPlus or general trends in coverage.  
Another focus of recent work has been the effect of insurance or free vaccines on where 
vaccines are received.  A survey of physicians found that those who participated in the VFC 
program were less likely to refer uninsured and Medicaid patients to the local health department 
(Zimmerman et al. 1997; Szilagyi et al. 2000).  A similar survey before and after implementation 
of the VFC program reported a statistically significant decline in referrals of the uninsured to 
public clinics associated with VFC in Pennsylvania, but not in Minnesota (Zimmerman et al. 
2001).  In New York State, researchers reported that the number of childhood vaccines 
administered by state health departments fell more than 50 percent between 1991 and 1996, 
years that bracket the introduction of the VFC and so called First Dollar Laws  (Szilagyi et al. 
2000).   
In summary, there is evidence that the cost of vaccines and the lack of health insurance 
are significant barriers to the receipt of immunizations in a “medical home.”  What is unclear is 
how immunization rates and sites of delivery have changed over the past eight years and how 
much of the change is associated with the growth in publicly provided health insurance.  
Although SCHIP has been targeted at children from near-poor families, aggressive outreach 
programs have also increased enrollment of children in Medicaid as well (Mann et al. 2002).  
Thus, we examine changes among poor and near-poor children.     - 7 - 
III.  Empirical Implementation 
1. The National Immunization Survey 
The National Immunization Survey (NIS) is a national probability sample of children  
ages 19 to 35 months.  There are 78 Immunization Action Plan areas representing 50 states and 
28 metropolitan areas in the sample.  Each IAP is a stratum and households are drawn randomly 
within each stratum.  Approximately 420 households are surveyed in each stratum each year for 
a total of about 34,000 households annually.  The survey uses a random-digit-dialing (RDD) 
design to identify households with children of the appropriate age and to survey them by phone.  
A person most knowledgeable about the child’s immunizations is asked to be the respondent.  
Each respondent is asked to locate a shot card if available.  In addition to information on the 
number and date of vaccines, respondents are asked about maternal schooling, family income, 
marital status, and other socio-demographic information.
5  Respondents are then asked 
permission to contact their immunization providers.  The second survey within the NIS is the 
provider record check (PRC).  Providers are mailed a survey in which they are asked to furnish 
the child’s vaccination history.  The initial mailing is followed up with reminders and telephone 
calls.  The 79 percent household response rate is impressively high for a RDD survey (Smith et 
al. 2001), as is the 94.6% response rate of providers questionnaires in 1999.  
  The provider data are generally considered the most reliable.  However, complete 
provider data are obtained for approximately 65 percent of the 34,000 households surveyed.  
Those with complete provider data are more likely to be white, better educated, and have greater 
incomes than households without provider data.  Aware of the potential problems associated with 
selective reporting, administrators of the NIS use propensity scores within each stratum to adjust 
                                                 
5 A list of the key variables is provided on page 40 of the User’s guide ( http://www.cdc.gov/nis/pdfs/nisdug01.pdf). 
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sampling weights for households with non-provider data (Smith et al. 2001).  The provider 
survey is the only source of information on the type of provider (e.g., public, private, VFC, etc.) 
and thus, generalizations as to the impact of SCHIP on where children obtain their 
immunizations is limited to this sample.
6  However, we also use the household survey for 
analyses related to the probability of being up to date for various vaccines.  We use all 
respondents with complete provider data as well as those who use a shot card to recall vaccines. 
There is good evidence that shot cards provide reliable information regarding vaccines, but that 
parental recall alone does not (Fierman et al. 1996;  Suarez, Simpson, Smith 1997).   We assume 
that there are no false positives on either the shot card or provider survey.  Thus, if a child is 
reported up-to-date for a vaccine based on either the shot card or the provider survey, then we 
assume that the child is up to date for that vaccine.  In Table 1 of the Appendix we provide a 
breakdown of the source of immunization information for the full seven year sample selected 
characteristics of the child or family.   
2. State Children Health Insurance Program 
The purpose of SCHIP is to extend health insurance to children in near-poor families that 
do not qualify for Medicaid, but who are uninsured.
7 Prior to SCHIP, Medicaid eligibility levels 
for all children up to age 6 were at least at 133 percent of the federal poverty level by law.  States 
had the option of raising them to virtually any level through provisions embodied in Section 
                                                                                                                                                             
 
6 The household survey asks each respondent how many vaccine providers they used.  We use those who saw only 
one provider as a positive indicator of continuity.  It is the only provider measure available from the household 
survey. 
7 In constructing SCHIP states have the option of extending Medicaid, creating a new insurance program or a 
combination of both.   Eighteen states and D.C. chose to extend Medicaid (M-SCHIP), 15 established separate 
programs (S-SCHIP) and 17 had combinations (C-SCHIP).   Evidence suggests that the distinction between M-
SCHIP and S-SCHIPS is not important with respect to its impact on the lack of insurance among children 
(Buchmueller and LoSasso 2002).  Consequently we do not analyze differences by program type.     - 9 - 
1902® (2) of the Social Security Act and still receive federal cost-sharing.   SCHIP allows states 
to raise the income eligibility thresholds above the Medicaid thresholds up to any level.
8  
We specify SCHIP in several ways.  First, we use dummy variables to capture the timing 
of program implementation for children zero to five years of age.  For instance, 8 states began 
enrollment of children in 1997, 33 in 1998, 8 in 1999 and 2 in 2000 (Rosenbach et al. 2001).  
We also use income eligibility thresholds to measure variation in generosity.  As of 2001, 14 
states had established income eligibility limits for children 1 to 5 years of age at above 200 
percent of the federal poverty level (FPL), 26 states at 200 percent of FPL and 11 at less than 200 
percent.
9  For years prior to SCHIP we use the Medicaid eligibility threshold for children 0 to 5 
years of age.  Figure 1 displays average income eligibility thresholds for infants and children one 
to five years of age.  The important point is that prior to SCHIP eligibility for infants was 
substantially greater than was eligibility for children and the thresholds of the two age groups do 
not merge until 2000. We use differences in the age of the child and differences in income 
eligibility thresholds between infancy and childhood as an additional source of variation.  
Specifically, the NIS has three categories for the child’s age: 19 to 23 months, 24 to 29 months 
and 30 to 35 months. Most vaccines are initiated in infancy.  Measles, mumps and rubella 
(MMR) and varicella vaccines begin at 12 months of age.  Consequently, the relevant income 
threshold is the one in place at the time vaccines are scheduled to begin.  Consider a child 19 to 
23 months in Massachusetts in 1998.  Use the median age of 21 months.  We assume that the 
child spends 12 of the 21 months (0.57) exposed to the threshold for infants in 1997 and 9 of 21 
                                                 
8 Initially, eligibility thresholds under SCHIP were only allowed up to 200 percent of the federal poverty level 
(FPL) or 50 percent above the minimum threshold that existed as of March 1997.  Soon after implementation of the 
plan this restriction was lifted due to a determination that Section 1902®(2) applied to SCHIP.   
 
9 Data on eligibility thresholds are from Lisa Dubay of the Urban Institute in Washington, D.C.    - 10 - 
months (0.43) exposed to the children’s eligibility level in 1998.  Thus, the average income 
eligibility threshold for this child is the weighted average of the Massachusetts’s threshold for 
infants in 1997 plus the threshold for children in 1998 with weights of 0.57 and 0.43, 
respectively. We follow an analogous procedure for infants 24 to 29 and 30 to 35 months and we 
modify the algorithm for vaccines that begin at 12 months. 
The NIS has measures of family income but they are not sufficiently refined so as to 
accurately measure eligibility for Medicaid and SCHIP.  There are 9 categories of income in the 
1995-1998 surveys and 15 categories in the 1999-2002 surveys.  The NIS uses an algorithm 
based on reported family income and family size to create an indicator of poverty status defined 
as below 100 percent of the federal poverty level.  In 1999, the NIS added a new variable that 
measures the ratio of income to poverty.  To create a consistent series of income to poverty, we 
used the income categories and family size to create an income to poverty ratio for 1995-1998.
10  
We then defined three categories of family: poor or those with < 100 percent of the FPL; near-
poor or those with income >=100 and <250 percent of the FPL; and non-poor those with income 
>=250 percent of the FPL and a separate category for unknown income.  We use these as broad 
measures of eligibility to define exposure to SCHIP.    
The effect of SCHIP on immunizations should vary by proportion of uninsured and 
underinsured children among the poor and near-poor as well as the pre-SCHIP level of 
immunization coverage rates.  For example, between 23 and 27 percent of near-poor and poor 
children respectively lacked health insurance in 1996, based on the Current Population Survey 
(Dubay, Hill and Kenny 2002).   However, such point-in-time calculations substantially 
                                                 
10 As a check on our measure, we used our algorithm to compute poverty status (< 100 FPL) and compared our 
poverty indicator to the one computed by NIS.  The associated kappa statistic ranged from .93 to .99 between 1995 
and 1998.    - 11 - 
underestimate the proportion of children that are uninsured for part of the year and overestimate 
children without insurance for the entire year (Congressional Budget Office 2003).  Furthermore, 
it is unclear how many children are “underinsured” by policies that do not cover some or all 
vaccines (Institute of Medicine 2000).   In addition, the rate of uninsured children varies 
substantially by state.  Data from the National Survey of American Families (NSAF), for 
instance, indicate that 34 percent of children from families with income below 200 percent of the 
FPL in Texas lacked insurance in 1997 as compared with 13.8 percent in Massachusetts (Kenny, 
Dubay and Haley 2000).   Finally, the measles epidemic was largely an urban phenomenon, 
concentrated in Los Angeles, Houston and Chicago among primarily poor and Hispanic children 
(National Vaccine Advisory Committee 1991).  To exploit these potential interactions, we 
present a series of analyses by states with high and low rates of uninsured children, by urban 
areas specifically designated as immunization action plan areas (IAP) by the NIS and by 
Hispanics.
11  
3.  Outcomes 
Our analysis concentrated on two policy relevant domains: the site where immunizations 
occurred and the likelihood of the child being up-to-date with immunizations.  Specifically with 
regard to the site of immunization receipt, we were interested in the degree to which SCHIP 
increased the probability of receiving all immunizations from a single provider as a surrogate 
marker of enhanced continuity of care.  As additional markers of pediatric care we subdivided 
single providers into private and public to test whether SCHIP was associated with shifts from 
public to private practice settings.  We also tested whether SCHIP was associated with an 
increased probability of receiving vaccines at a comprehensive pediatric provider, regardless of 
                                                 
11The CDC targeted selected urban areas with underserved populations.  Although these areas were to receive 
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public or private status.   This indication was added to the NIS in 1997.  Comprehensiveness is 
an important characteristic of pediatric health care indicating that, in addition to immunizations, 
children are receiving appropriate screening, developmental evaluation, nutrition assessment, 
behavioral counseling and other components of high quality preventive care. For each of these 
outcomes we compared the experience of poor and near-poor children with the trends among 
their non-poor counterparts. We hypothesized that an SCHIP effect on these outcomes would be 
most pronounced among near-poor children, but that we might also see an association with poor 
children as a spillover effect from SCHIP outreach initiatives. 
The second domain we investigated was the probability of being up-to-date with 
immunizations.  For the SCHIP, immunization receipt may be seen as an indirect marker of 
realized access to timely care.  The public use NIS provides data on individual immunizations as 
well as combinations.  We focus on two series of vaccines and two individual vaccines.  The 
accepted definition of being up-to-date with immunizations during the years we studied was to 
have received four diphtheria, tetanus and acellular pertussis vaccines (DtaP), three polio 
vaccines, one measles containing vaccine, and three Haemophilus influenza vaccines by eighteen 
months of age (http://www.cdc.gov/nip/publications/ACIP-list.htm).  For this reason we use this 
4:3:1:3 series as an important outcome of interest.   
The other series we use is the Hepatitis B series of three vaccinations by eighteen months 
of age.  Since many children actually receive all three of these vaccinations before a year of age, 
this series helps to characterize the immunization experience of infants during the first year of 
life more selectively than the 4:3:1:3 series part of which is not to be given before a year of age.  
In addition, the Hepatitis B vaccine is relatively new, recommended by the ACIP for all infants 
                                                                                                                                                             
additional resources to coordinate local efforts, funds were never forthcoming (Institute of Medicine 2000).    - 13 - 
in November of 1991(Centers for Disease Control and Prevention 1991).  As such, it may 
indicate how well new vaccines disseminate among different populations of children.   
We also chose to consider two individual vaccines as outcomes of interest.  The measles, 
mumps and rubella vaccine (MMR) given at one year of age, has obvious historical relevance 
since the measles epidemic of 1989-1990 constituted a major impetus for the development of the 
VFC program.  In addition, however, it is given at an age at which poor and near-poor children 
in many states are transitioning from one level of eligibility for public health insurance assistance 
to another.  It can, therefore, be instructive to contrast the income gradient for receipt of this 
vaccine with the income gradient for the Hepatitis B series that can be delivered before the first 
birthday.   
The final vaccine that interested us was the varicella vaccine principally as a test of 
whether SCHIP influenced the rate of uptake of newly introduced vaccines.  Licensed by the 
FDA in March of 1995, information on coverage in NIS was not available until 1997 (American 
Academy of Pediatrics 1995). It is, therefore, possible to trace the relative rate of uptake of this 
vaccine among poor and near-poor children compared with non-poor children as a function of 
SCHIP threshold levels.   
3.  Regression specification 
  SCHIP was established in 1997 although most state programs were not implemented until 
1998 or later.  Recall also that given the age of the children at survey, almost all began 
immunization between 1 to 2 years prior.  Consequently, coverage rates in 1997 largely represent 
vaccinations in 1995 and 1996, prior to implementation of the SCHIP.  Equation (1) below is a 
general representation of our reduced-form model.
12  
                                                 
12 For ease of presentation, we did not include unknown poverty and its interactions.   - 14 - 
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Yijt is a dichotomous indicator of whether child i, in state j and year t is up-to-date for a particular 
vaccine or up to date on a series; Yijt  may also be an indicator of whether the child received the 
vaccine in a comprehensive care setting. Poor and Nearpoor are indicator variables of poverty 
status as described above.   SCHIP in this specification is the average income eligibility 
threshold to which the child was exposed.  Note that SCHIP varies by age, state and year.  
Moreover, with state fixed effects identification comes from within-state changes in eligibility 
thresholds.  Finally, X is a matrix of maternal and child characteristics as well as the state 
unemployment rate and a measure of the Vaccine for Children program (VFC);
13 and λ j and δt 
are state and year fixed effects, respectively.  Summary statistics of selected characteristics by 
poverty status are presented in Table 2 of the Appendix.  
   The differential effect of SCHIP on poor and near-poor children is captured by the 
interaction terms. We expect β 4 and β 5 to be positive and as a first approximation we expect β 5 to 
exceed β 4 since many poor children would have been eligible for Medicaid prior to SCHIP.  
However, participation in Medicaid among poor children grew substantially between 1997 and 
                                                 
13 The VFC is a federal entitlement that makes free vaccines available to children on Medicaid, uninsured, Native 
American or Alaskan Native and to underinsured children who obtain vaccines at federally qualified health centers.  
The VFC began enrollment in 1994.  Provider participation rose rapidly and then leveled off in 1997.  We include 
the number of VFC sites per children less than 19 years of age.  The VFC is largely a supply-side intervention in 
which states purchase vaccines from the Centers for Disease Control and Prevention (CDC) and then distribute them 
to participating VFC providers.  Although the VFC lowers the cost to providers of providing vaccinations to 
uninsured children, the VFC does not cover the cost of the visit nor the administration of the vaccine.   Indeed, many 
physicians who participate in the VFC admitted that they would refer uninsured patients to the public health clinic 
for vaccinations (Zimmerman et al. 1997). SCHIP by contrast is a demand-side intervention that is awarded to 
parents and which covers the cost of the vaccine, its administration and the office visits.  
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2001, despite few changes in eligibility thresholds.  In an effort to enhance participation in 
SCHIP, many states expanded outreach.  More importantly, states also streamlined enrollment 
procedures in both their SCHIP and regular Medicaid programs.   Indeed, researchers recently 
reported that in 27 of the 38 states for which data were available, enrollment of children, families 
with children and pregnant women in “regular” Medicaid exceeded the number of children 
enrolled in SCHIP between 1997 and 2001 (Mann et al. 2002).  Thus, we expect β 4 to be 
positive; it may even exceed β 5.  
We use ordinary least squares to facilitate interpretation. None of the outcomes are in the 
extreme tails of the distribution and thus marginal effects from the linear and probit  
specifications are very similar.  All regressions are weighted by the sampling probabilities and 
we use robust regression procedures to account for the fact that we have only state variation in 




1.  Differences-in-Differences 
We present outcomes for the years before and after the implementation of  SCHIP.  We 
compare changes among poor and near-poor children to changes among the non-poor.  These 
differences-in-differences (DDs) provide an initial assessment as to the possible association 
between SCHIP and vaccination rates and sites of care.  Table 1 shows the proportion of children 
who obtained all vaccinations at one provider in 1996 and 2001, the years that largely bracket 
SCHIP.  Note that we have two measures of this outcome.  One is from the household survey and 
                                                 
14 We used survey procedures in Stata 8.0 to adjust the standard errors  for the sampling design in all bivariate 
comparisons.  In the regressions, however, there is no way with the survey procedures to account for the aggregate 
form of our program measure.   Thus, we use robust procedures that cluster on state.   - 16 - 
is based on parental recall.  The other is from the provider survey.  The comparison offers some 
insight into the sensitivity of the estimates from the two different sources.  We also compare 
changes in whether all vaccines were obtained at one private provider, one public provider and at 
a provider that offered comprehensive pediatric services (private or public) in 1996 and 2001.   
Substantial differences in vaccine sites between poor and non-poor in 1996 exist for those 
who obtained all vaccines at a private provider.   Forty-six percent of the poor, 51 percent of the 
near-poor and 72 percent of the non-poor received all vaccines at a single private provider in 
1996.   These differences increase for the poor in 2001.   As a result the DD for poor versus non-
poor are unexpectedly negative and statistically significant (DD1).  The other notable result from 
Table 1 is that the proportion of poor children who saw only one provider or only one provider 
that offered comprehensive pediatric services also fell relative to the non-poor between 1996 and 
2001.   There was no similar deterioration among the near-poor, but we had expected the 
availability of insurance to increase the proportion of children who used only one provider, one 
private provider and a comprehensive care provider.  
Vaccine coverage rates also differ by poverty in 1996.  Poor and near-poor children are 
less likely to be up to date for the 4:3:1:3 series, hepatitis B and varicella.   There are only 
modest differences for measles, mumps and rubella (MMR).  However, except for varicella, 
there is little narrowing in these differences in 2001.   The DDs are small in magnitude and 
statistically insignificant. The exception is varicella. In 1997, the first year for which data exist, 
21 percent of poor, 23 percent of near-poor and 37 percent of non-poor children were vaccinated 
against chicken pox.  By 2001 varicella coverage rates had increased dramatically: 77 percent, 76 
percent, and 81 percent for poor, near-poor and non-poor respectively.  The DDs for varicella are 
large and statistically significant, which is consistent with the extension of insurance to near-poor   - 17 - 
women.  However, children from poor families experience the greatest gain in coverage rates in 
both absolute and relative terms.  We expected that SCHIP would have had its most pronounced 
effect on near-poor children, but the increased enrollment in the Medicaid program may explain 
the results for poor children.  
2. Regression  results 
The DDs provide an initial look at changes in our outcomes but they do not exploit  
variation in the timing or the extensiveness of SCHIP.  To begin, we estimate equation (1) with 
dichotomous indicators for the year in which SCHIP was implemented and a one-year lag.   We 
estimate a second set of regressions with the SCHIP variable represented by income eligibility 
threshold to which a child was exposed.  Recall eligibility thresholds  vary by state, year, age and 
vaccine. In the years prior to SCHIP we use the income eligibility thresholds for Medicaid 
children 0 to 5 years of age.   
  In Table 3, we display the coefficients on interaction between the dichotomous indicators 
for SCHIP and poverty from equation (1) for two vaccines and two vaccine series. There are four 
panels; each represents a different sample: Panel A includes all 50 states and Washington D.C. 
and is directly comparable to the DD estimates in Table 2;  Panel B includes only the 28 urban 
Immunization Action Plan areas (IAPs);  Panel C has the 17 states with highest rates of 
uninsured children and Panel D includes only Hispanics from the nine states with the largest 
Hispanic populations.  The coefficients show the change in each vaccine or vaccine series among 
poor, near-poor and poverty unknown relative to non-poor children before and after 
implementation of SCHIP.  
As with the DDs in Table 2, the strongest association between SCHIP and up-to-date 
status is found for varicella.   Nationally, the probability that a poor or near-poor child was up to   - 18 - 
date for varicella increases between  7.0 and 7.4 percentage points more than among non-poor 
kids after SCHIP was implemented (Panel A).    Importantly, these changes essentially double 
when we limit the sample to 28 IAPs,  areas designated at risk for low immunization rates by the 
CDC (Panel B).   Changes in varicella coverage rates are also greater in the 17 states with the 
highest rate of uninsured children (Panel C) and among Hispanics in the 9 states with largest 
Hispanic populations (Panel D).   The same pattern exists among children for which poverty 
status is unknown.  This is not surprising given that the education, marital status, race, and urban 
residence of mothers from household of unknown poverty are most similar to those of poor and 
near-poor families (see Table 2 of the Appendix).  
Changes in the other vaccines are small and rarely of statistical significance in the 
national sample.   The probability that a child is up to date for the 4:3:1:3 series increased 3.7 
and 3.9 percentage points more among poor children and those of unknown poverty relative to 
non-poor children in states with high rates of uninsured children (Panel C).   Near-poor Hispanic 
children also experience a relative gain of 6.4 percentage points for 4:3:1:3 and a 3.3 percentage  
point gain for Hepatitis B vaccine.   
In Table 4 we show the same outcomes for the same samples but the coefficients 
represent the relative change associated with a 100 percentage-point increase in SCHIP income 
eligibility thresholds.  The average change between 1995 and 2001 is approximately 70 
percentage points.   Several points are relevant.  First, the results reveal a does-response effect 
between the magnitude of the change in eligibility thresholds and coverage rates for varicella.  
Specifically, a 100 percentage point increase in the income eligibility threshold is associated with 
a five percentage-point increase in the probability that a poor, near-poor or child of unknown 
poverty is up to date for varicella relative to a non-poor child across the U.S. (Panel A).  The   - 19 - 
second point is that the more vulnerable the population, the larger the effect of a 100 percentage 
point increase.  Finally, except for Hispanics and the 4:3:1:3 series (Panel D), there is no 
association between SCHIP eligibility thresholds and up-to-date status for the other vaccines. 
We estimate the same regressions for the site of vaccine delivery but find little 
association or an association opposite to what we expected (results not shown).  In short, they are 
few differences from the DDs in Table 1.  For completeness, we show these results in Appendix 
Table 3.  
A substantial portion of our sample lacks information on poverty: 24 percent in 1996 and 
11.5 percent in 2001.   We have presented all results for children from families in which poverty 
is not known.  Both the characteristics of these families and their association with SCHIP suggest 
that many are from poor or near-poor families.  As an additional check, we create three groups of 
children based on maternal schooling and marital status, both of which are highly correlated with 
family income in our sample.  Group 1 includes mothers who are not married and who have 12 
years of schooling or less.  Group 2 includes married women with 12 years of schooling or less 
and unmarried with 13 to 15 years of schooling.  Group 3, the most advantaged, includes married 
women with at least a college degree.   We then re-estimate the DDs in Table 2 and contrast 
Group 1 and Group 2 to Group 3.  The results are remarkably similar to those obtained using 
poor and near-poor children (available upon request). 
To summarize, we find that SCHIP is consistently associated with relative increases in 
varicella vaccine in both the simple DD and in the adjusted regression models.   There are 
modest and less consistent increases in Hepatitis B and in the 4:3:1:3 series among various 
subgroups.  In addition, increases are greater among groups at greater risk for lacking insurance 
or under immunization. To further examine the link between increased varicella coverage rates   - 20 - 
and SCHIP, we divide states by the year they implemented their SCHIP program: eight states in 
1997, 33 in 1998 and eight in 1999 and two in 2000.   We then run separate regressions of 
whether a child is up to date with respect to the varicella vaccine for each group of states (we 
combine 1999 and 2000).  However, instead of including an explicit measure of SCHIP, we 
interact the time dummies with indicators of poor, near-poor and children of unknown poverty.  
If SCHIP is responsible for the increase in varicella coverage rates, then we would expect to see 
relatively greater increases in varicella coverage rates in 1998 among near-poor kids from states 
that implemented SCHIP in 1997 than among kids from states that implemented SCHIP in 1999.   
In Figures 2 and 3 we plot the coefficients from the year/poor and year/near-poor interactions.  
Each point shows the change in varicella coverage rates between 1997 and each subsequent year 
relative to the change among non-poor children.  Thus, between 1997 and 1998, varicella 
coverage rates increase approximately 18 percentages points more among poor relative to non-
poor children in states that implemented  their SCHIP programs in 1997 (Figure 2).  However, 
there was a relative increase of 12 percentage-points  between 1997 and 1998 among poor 
children in states whose SCHIP programs did not begin until 1998 or later.  The results in Figure 
3 are also less than convincing as to a casual relationship between SCHIP and the uptake of 
varicella vaccine. The largest increase between 1997 and 1998 is among near-poor children in 
states whose SCHIP programs did not begin until 1999.  
3.  Sample Selection  
  As noted in Table 1 of the Appendix, respondents in the household survey for whom 
provider data were not available differ from respondents with provider data along several 
observable characteristics. The Centers for Disease Control and Prevention publishes annual 
vaccination rates based on the data obtained from the provider survey only, since these are   - 21 - 
considered the most reliable.  In order to minimize the loss of data, we included, whenever 
possible, all respondents with provider data along with all respondents who used a shot card to 
recall vaccines. Respondents with only a shot card tend to be poorer, less educated and more 
likely to be Hispanic than respondents with neither a shot card nor provider data (Appendix 
Table 1). 
  We check for the possibility of sample selection bias in several ways.   First, we re-run 
the basic regressions and limit the sample to children for whom only provider data are available.   
Our findings are not substantively altered.   In addition, in the household survey, respondents are 
asked how many vaccination providers they use.  We include as an outcome whether the 
respondent used only one provider for all vaccinations.  We compare results for this self-reported 
measure of provider use to results for the same outcome but based on data collected exclusively 
from providers.  A review of the DD estimates in Table 1 reveals no differences. Finally, we 
estimate a bivariate probit that allows for a cross-equation correlation.  The first equation is 
whether provider data are available for the respondent.  The second equation is whether the child 
is up to date for varicella. To improve identification, we exclude from the second stage an 
indicator of whether the child’s state of residence at the time of the survey is different from the 
child’s state of birth.   We assume the reasons for moving are unrelated to a child’s vaccinations.   
However, parents who move are much more likely to have more than one provider, which 
lessens the likelihood of being in the provider survey.  In our sample, for instance, 58 percent of 
the children who are born in states different from where they reside at the time of the survey 
obtain vaccines at more than one provider as compared to 29 percent who reside in the same 
state in which they were born.
15  
                                                 
15 The number of providers a child saw for vaccines is based on the household survey and not the provider survey.   - 22 - 
  In results not shown, we obtained a cross-equation correlation of 0.12 from estimation of 
the bivariate probit (p<0.01).   The positive correlation is expected: children more likely to be in 
the provider survey are more likely to be up to date for varicella vaccine.  However, the marginal 
effects of SCHIP in the varicella equation obtained from the bivariate probit are no different 
from those that we obtain when we restrict the cross-equation correlation to be zero.  In sum, we 
do not believe that merging the two sources of information on vaccine coverage alters our  
results in any meaningful manner.  
 
V. Conclusion 
There has been an unprecedented extension of publicly financed health insurance to poor 
and near-poor children since the mid 1980s.   SCHIP is the most recent example.  Numerous 
studies have linked increases in the availability of health insurance to increases in health care 
utilization among children.  However, measures of utilization are often too general to infer much 
about the quality of care or its effect on health.  In this study, we associated changes in SCHIP 
with changes in immunization coverage rates and the site at which vaccines are received.   
Vaccines are arguably the greatest public health achievement of the 20
th century, and a highly 
effective measure of both the quality of pediatric care as well as the improvement in health 
associated with vaccine preventable illnesses.  
We found little evidence to suggest that SCHIP has had a major impact on narrowing the 
immunization coverage rate gaps  among poor and near-poor children relative to their non-poor 
counterparts.  The one exception is the varicella vaccine in which differences in coverage rates 
between poor, near-poor and non-poor children converged rapidly between 1996 and 2001.  
Moreover, convergence was faster among poor and near-poor children from groups or areas with   - 23 - 
above average rates of uninsured children.  Unfortunately, improvements in varicella coverage 
cannot be tightly linked to the timing of SCHIP program implementation and thus, we caution 
against a causal interpretation.  The association, however, is a potentially important finding if it 
suggests that health insurance plays a substantive role in the uptake of new vaccines. The 
pneumococcal conjugate recommended for all children in 2001, not only protects against the 
most common cause of bacterial meningitis, but also lowers the incidence of acute otitis media, a 
common childhood illness (Eskola et al. 2001).   The pneumococcal vaccine, however, is costly.   
At approximately $200 for a series of four doses, it is twice as expensive as the varicella vaccine.  
The availability of insurance may be a significant determinant of its uptake among poor and 
near-poor children.   
Our results for the varicella vaccine point to substantial “spillover” effects associated 
with SCHIP.   We generally found greater convergence in coverage rates among poor children 
even though most were likely eligible for publicly provided insurance before SCHIP.   If the 
outreach efforts and the simplification of enrollment procedures are responsible for the uptake 
among Medicaid-eligible children, and if such reforms would not have occurred without SCHIP, 
then in a reduced-form sense, the results for poor and near-poor children are a consequence of 
the SCHIP initiative.   
The other unexpected result was the decline in the proportion of children who received 
vaccines at a single provider or a single private provider. We had anticipated that SCHIP would 
increase the proportion of near-poor children within “medical homes.”  It may be that the 
complexity of the immunization schedule combined with the expense associated with  fully 
vaccinating a child, and the large number of near-poor children who cycle in and out of different 
insurance plans during the course  of  a given  year  encouraged many parents to obtain vaccines   - 24 - 
in both the private and public sector, in a kind of “catch as catch can” approach to 
immunizations.    This is not a welcome result.  Multiple sites complicate record keeping, 
confound reminder systems, and lessen the opportunities for pediatric screening, particularly if 
vaccines are obtained in public health clinics that do not provide comprehensive services.  In 
sum, it appears that great strides have been made at improving age-appropriate coverage rates 
among poor and near-poor children since the measles epidemic in 1990.  The challenge going 
forward will be  to devise both supply and demand side mechanisms that encourage parents to 
establish a “medical home” for pediatric care. 
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Proportion of Vaccines Obtained by Characteristics of the Provider, Poverty Status and Year: 1996 
and 2001 
 
Panel A – 1996:  Poor  Near-Poor  Non-Poor  Unknown  D1  D2  D3 
(1) (2) (3) (4)  (1-3)  (2-3)  (4-3) 
         
1 Provider  0.821 0.798 0.827 0.829  -0.006  -0.029**    0.002 
1 Provider (R)  0.673 0.657 0.714 0.695  -0.041**  -0.057**  -0.019 
1 Private provider  0.457 0.510 0.722 0.526  -0.266**  -0.212**  -0.196** 
1 Public provider  0.284 0.246 0.097 0.231    0.187**  0.148**    0.134**
1 Comp. Care  0.679 0.686 0.747 0.726  -0.068**  -0.061**  -0.020 
N  3323 6779 9865 6341       
Panel B – 2001:  Poor  Near-Poor  Non-Poor  Unknown  D4  D5  D6 
(5) (6) (7) (8)  (5-7)  (6-7)  (8-7) 
         
1 Provider  0.804 0.812 0.857 0.824  -0.053**  -0.044**  -0.032* 
1 Provider (R)  0.650 0.667 0.743 0.706  -0.093**  -0.076**  -0.037* 
1 Private provider  0.402 0.554 0.763 0.556  -0.361**  -0.210**  -0.207** 
1 Public provider  0.284 0.188 0.057 0.178    0.227**    0.131**    0.121** 
1 Comp. Care  0.642 0.663 0.743 0.681  -0.101**  -0.080**  -0.062** 
N  5132  8051 10951 3140       
Difference in Differences 2001-1996:    DD1  DD2  DD3 
       (D4-D1) (D5-D2) (D6-D3) 
          
     1 Provider    -0.047**  -0.016  -0.034 
       (0.017) (0.014) (0.018) 
    1  Provider  (R)    -0.052**  -0.019  -0.018 
       (0.019) (0.015) (0.019) 
    1  Private  provider    -0.095**  0.002  -0.011 
       (0.024) (0.018) (0.024) 
    1  Public  provider  0.040 -0.017 -0.013 
       (0.021) (0.013) (0.017) 
    1  Comp.  Care  -0.034 -0.019    -0.042* 
       (0.022) (0.016) (0.021) 
* significant at 5%; ** significant at 1%.  The outcomes refer to children who obtain all vaccines at one Provider, one 
Private Provider, one Public Provider and one Provider that offers comprehensive pediatric services as record by the 
provider survey or at one Provider (R) as recorded by the household survey.  Columns headed by a “D” represent first 
differences and those headed by “DD” are difference-in-differences.  Standard errors adjusted for the survey design are 
in parentheses.   
 
Table 2. 
Proportion of Children 19 to 35 Months of Age Up to Date (UTD) for Vaccine Series (4:3:1:3) and 
Selected Other Vaccines by Poverty Status and Year: 1996 and 2001 
 
Panel A – 1996:  Poor  Near-Poor  Non-Poor  Unknown  D1  D2  D3 
(1) (2) (3) (4)  (1-3)  (2-3)  (4-3) 
         
UTD 4:3:1:3  0.687 0.755 0.816 0.709  -0.128**  -0.061**  -0.107** 
UTD MMR  0.910 0.928 0.945 0.921  -0.035**  -0.016**  -0.024** 
UTD Hepatitis B  0.812 0.843 0.869 0.821  -0.057**  -0.026**  -0.048** 
UTD Varicella  0.205 0.234 0.370 0.253  -0.165**  -0.136**  -0.117** 
N  3323 6779 9865 6341       
Panel B – 2001:  Poor  Near-Poor  Non-Poor  Unknown  D4  D5  D6 
(5) (6) (7) (8)  (5-7)  (6-7)  (8-7) 
         
UTD 4:3:1:3  0.710 0.764 0.824 0.737  -0.113**    -0.060**  -0.087** 
UTD MMR  0.919 0.924 0.947 0.931  -0.028**    -0.023**  -0.015 
UTD Hepatitis B  0.875 0.904 0.916 0.871  -0.041**  -0.013*  -0.045** 
UTD Varicella  0.766 0.759 0.814 0.784  -0.048**      -0.055**  -0.030* 
N  5132  8051 10951 3140       
         
Difference in Differences 2001-1996:    DD1  DD2  DD3 
       (D4-D1) (D5-D2) (D6-D3) 
          
     UTD 4:3:1:3  0.015 0.001 0.020 
       (0.018) (0.014) (0.017) 
    UTD  MMR  0.006 -0.006 0.008 
       (0.011) (0.008) (0.010) 
    UTD  Hepatitis  B  0.016 0.014 0.003 
       (0.014) (0.010) (0.013) 
    UTD  Varicella     0.117**     0.081**     0.087** 
       (0.017) (0.014) (0.017) 
* significant at 5%; ** significant at 1%.  See notes to Table 1.  The up-to-date 4:3:1:3 series represents four diphtheria, 
tetanus and acellular pertussis vaccines (DtaP), three polio vaccines, one measles containing vaccine, and three Haemophilus 




Regression Estimates of the Association between the Up to Date Status of Vaccines and the 
Implementation of the State Children’s Health Insurance Program (SCHIP) for Children 19 to 35 
Months by Poverty Status for Entire U.S. and Selected Sub-groups, 1995-2001
+ 
 
  UTD 4:3:1:3  UTD Hepatitis B  UTD MMR  UTD Varicella 
  Panel A: National estimates  
1.poor - non-poor   0.012  0.006   0.016*    0.070** 
  (0.018)  (0.015) (0.008) (0.023) 
2.near-poor - non-poor  0.012   0.014*  0.004    0.074** 
  (0.011)  (0.007) (0.005) (0.012) 
3.pooruk - non-poor  0.022  0.004  0.010    0.051** 
  (0.013)  (0.006) (0.006) (0.019) 
N  183973  183973 184115 134416 
R-squared  0.094  0.072 0.019 0.182 
  Panel B: 28 Urban Immunization Action Plan areas only: 
1.poor - non-poor  -0.005  0.020  0.027    0.157** 
  (0.026)  (0.023) (0.014) (0.037) 
2.near-poor - non-poor  -0.001  0.003  0.022    0.147** 
  (0.022)  (0.012) (0.012) (0.039) 
3.pooruk - non-poor  0.017  0.017  0.016    0.121** 
  (0.024)  (0.017) (0.010) (0.039) 
N  63790 63790  63831  47211 
R-squared  0.113  0.070 0.020 0.197 
  Panel C: 17 states with the highest rate of uninsured kids in 1995-1997 
1.poor - non-poor   0.037*  0.007    0.023**    0.105** 
  (0.016)  (0.024) (0.009) (0.038) 
2.near-poor - non-poor  0.026  0.009  -0.001    0.099** 
  (0.016)  (0.008) (0.008) (0.018) 
3.pooruk - non-poor   0.039*  0.000  0.002   0.077* 
  (0.019)  (0.009) (0.007) (0.036) 
N  71950 71950  72001  53124 
R-squared  0.089  0.066 0.016 0.192 
  
 
Table 3. Continued: 
 
  UTD 4:3:1:3  UTD Hepatitis B  UTD MMR  UTD Varicella 
  Panel D: Hispanics only, in 9 states with large Hispanic population 
1.poor - non-poor   0.031  0.013  -0.023*     0.138** 
  (0.037) (0.031)  (0.010)  (0.043) 
2.near-poor - non-poor      0.064**    0.033*  -0.023     0.120** 
  (0.021) (0.017)  (0.018)  (0.036) 
3.pooruk - non-poor   0.062*  0.025  -0.029     0.120** 
  (0.029) (0.021)  (0.018)  (0.042) 
N  20188 20188  20194  15412 
R-squared  0.111 0.085  0.018  0.217 
* significant at 5%; ** significant at 1%.   Estimates obtained by ordinary least squares.  Robust standard errors 
have been adjusted for clustering at the state or IAP level. All models include state (or IAP) and year fixed effects.  
Figures show the differential change in the probability of each outcome as shown in equation (1).  The 28 IAPs 
include MA-City of Boston, NJ-City of Newark, NY-NYC 5 Counties, District of Columbia, MD-City of Baltimore, 
PA-Philadelphia County, AL-Jefferson County, FL-Duval County, FL-Dade County, GA-Fulton/Dekalb Counties, 
TN-Shelby County, TN-Davidson County, ILl-City of Chicago, IN-Marion County, MI-City of Detroit, OH-
Cuyahoga County, OH-Franklin County, WI-Milwaukee County, LA-Orleans Parish, TX-Dallas County, TX-El 
Paso County, TX-City of Houston, TX-Bexar County, AZ-Maricopa County, CA-Los Angeles County, CA-Santa 
Clara County, CA-San Diego County, WA-King County.  The 17 states with the highest rate of uninsured children 
between 1995-1997 include Arizona, Arkansas, California, Colorado, District of Columbia, Florida, Georgia, Idaho, 
Louisiana, Mississippi, Nevada, New Jersey, New Mexico, North Carolina, Oklahoma, South Carolina, Texas.  The 
9 states with largest Hispanic population are: Arizona, California, Florida, Illinois, Massachusetts, New Jersey, New 
Mexico, New York, Texas.  
 
Table 4. 
Regression Estimates of the Association between the Up to Date Status of Vaccines and Income 
Eligibility Thresholds for the State Children’s Health Insurance Program (SCHIP) for Children 19 
to 35 Months by Poverty Status for Entire U.S. and Selected Sub-groups, 1995-2001
+ 
 
  UTD 4:3:1:3  UTD Hepatitis B  UTD MMR  UTD Varicella 
  Panel A: National estimates  
1.poor - non-poor   0.026 -0.001  0.008    0.051* 
  (0.017)  (0.015) (0.009) (0.025) 
2.near-poor - non-poor  0.017  0.021  -0.004    0.052** 
  (0.015)  (0.013) (0.007) (0.018) 
3.pooruk - non-poor  0.026  0.004  0.003    0.054** 
  (0.020)  (0.010) (0.006) (0.011) 
N  183973  183973 184115 134416 
R-squared  0.094  0.072 0.019 0.182 
  Panel B: 28 Urban Immunization Action Plan areas only: 
1.poor - non-poor  0.006 0.002  0.027    0.092* 
  (0.021)  (0.023) (0.022) (0.040) 
2.near-poor - non-poor  -0.012 0.014 0.018 0.060 
  (0.037)  (0.024) (0.025) (0.057) 
3.pooruk - non-poor  0.024  0.027  0.025    0.105** 
  (0.053)  (0.030) (0.018) (0.031) 
N  63790 63790  63831  47211 
R-squared  0.113  0.069 0.020 0.196 
  Panel C: 17 states with the highest rate of uninsured kids in 1995-1997 
1.poor - non-poor  0.035  0.000  0.014    0.089** 
  (0.034)  (0.025) (0.017) (0.029) 
2.near-poor - non-poor  0.031  0.027  -0.013    0.077** 
  (0.033) (0.014)  )  (0.014) (0.016) 
3.pooruk - non-poor  0.053  0.008  0.000    0.063** 
  (0.045)  (0.011) (0.008) (0.022) 
N  71950 71950  72001  53124 
R-squared  0.088  0.066 0.015 0.191  
 
Table 4. Continued: 
 
  UTD 4:3:1:3  UTD Hepatitis B  UTD MMR  UTD Varicella 
  Panel D: Hispanics only, in 9 states with large Hispanic population 
1.poor - non-poor      0.054**  0.036  -0.016   0.091* 
  (0.014) (0.042)  (0.013)  (0.040) 
2.near-poor - non-poor   0.079** 0.057  -0.007  0.047 
  (0.017) (0.037)  (0.020)  (0.034) 
3.pooruk - non-poor      0.105**  0.059  -0.024    0.084** 
  (0.023) (0.045)  (0.016)  (0.031) 
N  20188 20188  20194  15412 
R-squared  0.110 0.085  0.017  0.215 
* significant at 5%; ** significant at 1%.   See notes to Table 3.  
 
Appendix Table 1.  
Source of Immunization Information by Characteristics of the Child/Family,  
National Immunization Survey 1995-2001 
 
















(1) (2)  (3) (4) (5)  (1 vs.(2-4))  (1 vs. 3) 
Child's Age:           
19-23  months  0.297  0.303 0.294 0.301 0.292  -0.002    0.003 
24-29  months  0.351  0.346 0.353 0.354 0.349  -0.001  -0.002 
30-35  months  0.351  0.351 0.353 0.345 0.359    0.002  -0.002 
Mother's Race:           
White  Non-Hisp.  0.614  0.529 0.673 0.617 0.588  -0.007**  -0.059** 
Black  Non-Hisp. 0.150  0.144 0.158 0.107 0.210    0.017**  -0.008** 
Hispanic  0.186  0.269 0.126 0.225 0.150  -0.010**    0.060** 
Other  0.050  0.059 0.043 0.051 0.051    0.000    0.007** 
Number of Children:         
1  0.285  0.285 0.275 0.288 0.293    0.002    0.010** 
2-3  0.589  0.580 0.607 0.594 0.563  -0.007**  -0.018** 
4 or more  0.123  0.131  0.116  0.116  0.136   0.004*   0.006** 
Unknown  0.003  0.004 0.001 0.001 0.008    0.001**    0.002** 
Marital Status:           
Married  0.714  0.716 0.707 0.751 0.660  -0.015**    0.006* 
Widowed/Divorced  0.090  0.082 0.098 0.078 0.106    0.004**  -0.007** 
Single  0.193  0.198 0.194 0.170 0.226    0.009**  -0.001 
Unknown  0.003  0.004 0.001 0.001 0.008    0.001**    0.002** 
Mother's Education:         
<  12  years  0.165  0.206 0.133 0.183 0.150  -0.004*    0.032** 
12  years  0.387  0.382 0.395 0.367 0.412    0.007**  -0.008* 
13-15  years  0.166  0.156 0.177 0.162 0.165    0.000  -0.011** 
≥16 years  0.282  0.257 0.295 0.287 0.273  -0.003  -0.014** 
Poverty Status:           
Poor    0.171  0.185 0.161 0.185 0.151  -0.005**    0.009** 
Near-Poor  0.270  0.254 0.282 0.289 0.234  -0.010**  -0.012** 
Non-Poor    0.334  0.271 0.381 0.344 0.296  -0.010**  -0.048** 
Unknown  0.226  0.289 0.175 0.182 0.320    0.026**    0.050** 
Male  0.511  0.517 0.512 0.508 0.513    0.000  -0.001 
Mobility  0.097  0.141 0.070 0.083 0.127    0.008**    0.028** 
Live in Urban Area  0.217  0.290  0.173  0.216  0.229   0.003**   0.044** 
N  232,521  32,787 71,012 79,913 48,809     
* significant at 5%; ** significant at 1% 
 
Appendix Table 2. 
Characteristics of Mother and Child by Poverty Status, National Immunization Survey, 
1995-2001. 
 
 Poor  Near-Poor  Non-Poor  Unknown 
      
Child's Age:      
19-23  months  0.303 0.294 0.295 0.300 
24-29  months  0.351 0.349 0.353 0.351 
30-35  months  0.345 0.357 0.351 0.350 
      
Mother's Race:      
White  Non-Hisp.  0.353 0.648 0.804 0.490 
Black  Non-Hisp.  0.258 0.139 0.078 0.186 
Hispanic  0.341 0.169 0.070 0.263 
Other  0.048 0.044 0.048 0.061 
      
Number of Children:     
1  0.233 0.269 0.358 0.235 
2-3  0.558 0.615 0.593 0.578 
4  or  more  0.209 0.116 0.049 0.173 
Unknown  0.000 0.000 0.000 0.014 
      
Marital Status:      
Married  0.446 0.744 0.908 0.592 
Widowed/Divorced  0.162 0.089 0.042 0.110 
Single  0.392 0.167 0.050 0.286 
Unknown  0.000 0.000 0.000 0.012 
      
Mother's Education:      
<  12  years  0.354 0.125 0.026 0.274 
12  years  0.459 0.485 0.256 0.409 
13-15  years  0.118 0.207 0.187 0.124 
≥16  years  0.069 0.183 0.530 0.194 
      
Male  0.507 0.512 0.511 0.515 
Mobility  0.100 0.088 0.077 0.136 
Live in Urban Area  0.288  0.183  0.165  0.282 
N  36878 64114 82960 48569 
Footnote:  Poor is defined as family income < 100% Federal poverty level; Near-poor 100-<250% FPL, Non-
poor >=250% FPL.   Mobility means the child’s state of residence at the interview differed from his/her state of 
birth.  Urban areas represent  28 Immunization Action Plan  areas (IAPs) designated by the CDC.  See the note 
to Table 3 in the text for a list of the IAPs.  
 
Appendix Table 3. 
Regression Estimates of the Association between the Probability that a Child Obtained All Vaccines 
at a Type of Provider and the Implementation of the State Children’s Health Insurance Program 










  Panel A: National estimates  
1.poor - non-poor   -0.013 -0.015  -0.039* 0.021  0.004 
  (0.010) (0.011) (0.020) (0.014) (0.019) 
2.near-poor - non-poor  -0.004 -0.014 -0.007 -0.012 0.004 
  (0.008) (0.008) (0.010) (0.009) (0.015) 
3.pooruk - non-poor  0.009 -0.010 -0.014 -0.015 -0.004 
  (0.008) (0.011) (0.016) (0.010) (0.019) 
N  220882 150925 132836 132836 113643 
R-squared  0.041 0.023 0.127 0.123 0.038 
  Panel B: 28 Urban Immunization Action Plan areas only: 
1.poor - non-poor  -0.007 0.000 0.009 -0.008 0.026 
  (0.009) (0.010) (0.035) (0.027) (0.017) 
2.near-poor - non-poor  -0.024  -0.042 -0.050* -0.014  -0.014 
  (0.013) (0.025) (0.025) (0.015) (0.020) 
3.pooruk - non-poor  0.017 -0.012 -0.017  -0.032*  0.003 
  (0.012) (0.019) (0.022) (0.016) (0.023) 
N  78438 50303 43822 43822 38369 
R-squared  0.036 0.021 0.141 0.111 0.030 
  Panel C: 17 states with the highest rate of uninsured kids in 1995-1997 
1.poor - non-poor  0.006 0.008 0.013 -0.018 0.034 
  (0.014) (0.014) (0.025) (0.020) (0.023) 
2.near-poor - non-poor  0.002 -0.013 0.002  -0.036*  0.026 
  (0.011) (0.010) (0.016) (0.015) (0.025) 
3.pooruk - non-poor  0.025 0.007 0.011    -0.047**  0.047* 
  (0.013) (0.011) (0.015) (0.011) (0.023) 
N  87107 57029 50040 50040 43451 
R-squared  0.033 0.017 0.137 0.147 0.032 
  
 
Appendix Table 3. Continued: 
 






  Panel D: Hispanics only, in 9 states with large Hispanic population 
1.poor - non-poor   -0.012 -0.014 -0.007 0.036 -0.023 
  (0.037) (0.041) (0.040) (0.029) (0.050) 
2.near-poor - non-poor   -0.026 -0.043 -0.010 -0.003  -0.067* 
  (0.034) (0.028) (0.025) (0.023) (0.027) 
3.pooruk - non-poor   -0.008  -0.014  -0.013   -0.055** -0.058 
  (0.033) (0.031) (0.055) (0.019) (0.034) 
N  23362 15024 13038 13038 11911 
R-squared  0.022 0.015 0.089 0.094 0.026 
* significant at 5%; ** significant at 1%.   See notes to Table 3 in the text. 